What is a retrade in M&A, and what can a seller do about it?

What a retrade means

A retrade is a renegotiation the buyer opens after the seller has granted exclusivity: the price in the letter of intent (LOI) drops, or the same headline price comes back with more of it deferred, escrowed or contingent. The buyer usually points to something found in diligence, such as lower normalized EBITDA in the quality of earnings (QoE) report or a customer that left during the process.

Timing is what makes it painful. Once the LOI is signed, the seller has stopped talking to other bidders, management has spent weeks answering requests, and the owner may have told family or key staff that a deal is coming. The buyer knows that walking away is now expensive for the seller.

Not every price change is bad faith. A buyer that finds a real problem is entitled to reprice it. The advisor's first job is to decide whether the finding is new, material and quantified, or whether it is leverage.

Why do retrades happen?

Most retrades trace back to a gap between the confidential information memorandum (CIM) and what diligence finds, or to a change in the buyer's own position.

The last row deserves attention. A financing-driven retrade is the buyer's problem, not a diligence finding, and the seller's answer should say so.

What forms does a retrade take?

A retrade is not always a lower headline number. Buyers often hold the price and move risk onto the seller instead:

• More consideration moved into an earnout, a seller note or rollover equity
• A larger escrow or holdback, or a longer survival period for representations
• A higher net working capital peg, which reduces cash at closing through the adjustment
• New special indemnities for an issue found in diligence
• Broader definitions of debt-like items, which cut equity value in a cash-free, debt-free deal

The M&A terms glossary defines each of these structures and the data licensing terms they can collide with.

Retrade vs similar terms

How can a seller prevent or answer a retrade?

Most of the defense happens before the LOI is signed. A sequence that holds up well:

1. Commission a sell-side QoE before marketing, so add-backs are tested by someone the seller hired.
2. Write the working capital method, the definition of debt and the diligence scope into the LOI itself.
3. Keep exclusivity as short as the buyer will accept, and tie any extension to progress on the purchase agreement.
4. Ask for every retrade in writing, with the finding, the dollar effect and the supporting workpaper.
5. Trade rather than concede: if price moves, ask for something back, such as a smaller escrow or a faster close.
6. Keep runner-up bidders warm within what the no-shop clause allows, after checking the wording with counsel.

Our explainer on LOI no-shop and exclusivity clauses covers what that clause usually restricts.

Market conditions shape leverage too. Bain's Global Private Equity Report 2026 counted about 32,000 unsold companies worth $3.8 trillion, so sponsor-owned sellers compete with a large backlog for buyer attention. When buyers have plenty of alternatives, expect them to test price harder.

Where a separate data license fits

A retrade attacks the one number the buyer controls. Some owners also hold value the buyer is not paying for and cannot reprice: years of operational records that AI labs and data buyers license to train and evaluate AI agents.

A data license through SourceX is a separate transaction with a separate counterparty. The company keeps ownership of its records, approves scope and price, and receives one all-in, one-time payment. Nothing is binding until the company signs.

Three cautions before raising it mid-process:

• Timing. Licensing during exclusivity can collide with no-shop or interim operating covenants. Settle it with deal counsel, or plan it before the LOI or after closing.
• Disclosure. A license, including any exclusivity for AI training, belongs on the disclosure schedule. The M&A closing checklist lists the consent and notice lines.
• Ownership after closing. If no license is signed before the sale, the records normally pass with the company. See who owns company data after an acquisition.

A license will not stop a retrade. It reduces how much of the owner's outcome rides on one buyer's diligence. This is general information, not legal, tax or financial advice.

Illustrative example

Illustrative and fictional: Larkfield Freight Services, a 140-person freight brokerage, signs an LOI with a financial buyer. Six weeks into exclusivity, the buyer's QoE removes two owner add-backs and the buyer proposes moving part of the price into an earnout. The sell-side advisor defends one add-back with workpapers, accepts the other, and trades a smaller earnout for a shorter escrow. Separately, the owner had screened the company months earlier because its dispatch, carrier negotiation and claims records went back nine years; that conversation runs on its own track, timed with counsel.

Which sellers are worth screening for licensing?

The records side applies to US companies with 50+ full-time employees at peak (contractors excluded), several years of documented operations, rights to license the material and an authorized sponsor such as the owner or CEO. Clients whose records mostly belong to their own customers, or are mainly consumer or health data, rarely fit. The who qualifies page has the full baseline, and the company fit checker gives a preliminary, non-binding read.

Partners earn 25% of the eligible platform fees SourceX actually collects from the referred company's licensing deals, capped at $100,000 per referred company. Rewards are paid only after the buyer pays and SourceX receives its fee, no reward is guaranteed, and the reward never reduces what the client receives. Check your engagement letter and any professional rules that apply to you first.

Next step

If a seller in your pipeline holds years of operational records, register as a partner and make the introduction. The program page for M&A advisors explains how introductions fit alongside a sale mandate.